Our study aimed to evaluate CDs160/CD200 expression in CLPD that is presented in leukemic phase which can be misdiagnosed as CLL when atypical clinical, morphological, histochemical, immunophenotypic and/or molecular presentation are affected. This evidence concerns the gene CD200 and B-cell chronic lymphocytic leukemia.